2026-07-24T06:25:21Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/91082025-05-08T18:07:52Zcom_20.500.12105_2052com_20.500.12105_2051com_20.500.12105_15322col_20.500.12105_19609col_20.500.12105_16983

00925njm 22002777a 4500 dc Requena-Méndez, Ana author Salas-Coronas, Joaquin author Salvador, Fernando author Gomez-Junyent, Joan author Villar-Garcia, Judith author Santin, Miguel author Muñoz, Carme author González-Cordón, Ana author Cabezas Fernández, Maria Teresa author Sulleiro, Elena author Arenas, Maria Del Mar author Somoza, Dolors author Vázquez-Villegas, José author Treviño, Begoña author Rodriguez, Esperanza author Valls, Maria Eugenia author LLaberia-Marcual, Jaume author Subirá, Carme author Muñoz, Jose author 2020-02-11 Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S.stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S.stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S.stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI -0.3-6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression. Pathogens. 2020 Feb 11;9(2). pii: E107. 10.3390/pathogens9020107 2076-0817 Pathogens (Basel, Switzerland) 32053864 http://hdl.handle.net/20.500.12105/9108 Spain Strongyloides stercoralis Migrants Prevalence Strongyloidiasis High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study